[Featured Stock] Zetema Obtains Patent for Commercialization of Lipolysis Injection

[Asia Economy Reporter Hyungsoo Park] Zetema is showing strong performance. The news of obtaining a patent related to 'local injection composition' appears to have influenced the stock price.

As of 2:59 PM on the 15th, Zetema is trading at 24,800 KRW, up 2.48% from the previous day.

Zetema introduced that the fat-dissolving injection is a freeze-dried dry powder formulation with excellent storage stability. They explained that since the pH is below 8.2, when dissolved in injection water, it creates a pH environment closer to the human body compared to conventional injections, resulting in less injection pain. They emphasized that DCA does not precipitate and dissolves well in injection water.

Zetema stated that they will commercialize the fat-dissolving injection using the patent.